
Thomas Seufferlein
Thomas Seufferlein is a gastroenterologist and cancer specialist at the University Hospital Ulm in Germany, recognized for his expertise in treating pancreatic cancer. He has been vocal about the potential of the new drug Daraxonrasib and its implications for early intervention in cancer treatment.
Power618
Reach7,645
Country presence
Recent news mentions
Thomas Seufferlein is a cancer specialist and gastroenterologist from the University Hospital Ulm who discussed the potential benefits of administering the drug earlier.
Durchbruch mit neuem Medikament DaraxonrasibNeue Zürcher Zeitung·
Switzerland· 2026-07-21


